Page 2 - Thomas Scriba News Today

The candidate is moving to long-awaited phase III trials — if successful, it would be the first new jab against the disease in more than 100 years. The candidate is moving to long-awaited phase III trials — if successful, it would be the first new jab against the disease in more than 100 years.

UK based cardiologist and anti-vaxxer Aseem Malhotra's visit to South Africa has raised public safety concerns among clinicians, scientists, and public health specialists in South Africa and beyond. 

Vaccination against Mycobacterium tuberculosis (M. tb) infection and Tuberculosis (TB) disease

As the sub-lineages of Omicron continue to spread ahead of winter, experts stress the need for people to get vaccinated and boosted.

The level of research and investment poured into Covid-19 should also be applied to other deadly, infectious disease killers, such as TB, say SA experts.


Many countries, including SA, are offering booster shots to parts of the population. We take a look at what the data say about their safety and who needs them most.


Past infection is unlikely to provide protection against reinfection with Omicron – but will this immunity, and that from vaccines, protect against severe disease?


Tiyese Jeranji looks at a new fingerstick blood test that may help diagnose more people quicker.

The World Health Organization estimates that more than four million of the almost 10 million people who fell ill with tuberculosis in 2020 were not diagnosed. One obstacle to more people being diagnosed is that most current tests require people to produce sputum — which children and some peop...

No new vaccine for TB developed since BCG was first used 100 years ago